Quantcast

Health Care Sector Update for 03/01/2019: IMGN, MRSN, PBYI, JNJ, PFE, MRK, ABT, AMGN


Shutterstock photo

Top Health Care Stocks:

JNJ: +0.26%

PFE: +0.37%

ABT: Flat

MRK: Flat

AMGN: Flat

Friday pre-bell saw flat to higher health care majors.

Stocks moving on news include:

(-) ImmunoGen ( IMGN ), which was sinking by more than 47% after announcing that its late-stage "Forward I" trial evaluating mirvetuximab soravtansine compared to chemotherapy in patients with ovarian cancer did not meet its primary endpoint of "progression-free survival" ( PFS ) in either the entire study population or in the pre-specified subset of patients with high FRa expression.

(-) Mersana Therapeutics ( MRSN ) was down over 28% after pricing its underwritten public offering of 21,250,000 shares at $4.00 per share, below the stock's $5.51 close on Thursday, for gross proceeds of approximately $85.0 million.

(+) Puma Biotechnology ( PBYI ) was up more than 29% after its adjusted net loss narrowed to $0.32 per share in Q4 from $1.03 per share a year earlier, a smaller loss than analysts' estimates of $0.42 loss per share in a Capital IQ poll.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.





This article appears in: Investing , US Markets
Referenced Symbols: IMGN , PFS , MRSN , PBYI , JNJ




More from MT Newswires

Subscribe






MT Newswires
Contributor:

MT Newswires

Market News, Commodities












Research Brokers before you trade

Want to trade FX?